Logo image of AWRE

AWARE INC/MASS (AWRE) Stock Fundamental Analysis

NASDAQ:AWRE - Nasdaq - US05453N1000 - Common Stock - Currency: USD

1.87  -0.05 (-2.6%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AWRE. AWRE was compared to 284 industry peers in the Software industry. While AWRE has a great health rating, there are worries on its profitability. AWRE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AWRE had negative earnings in the past year.
AWRE had a negative operating cash flow in the past year.
AWRE had negative earnings in each of the past 5 years.
In the past 5 years AWRE reported 4 times negative operating cash flow.
AWRE Yearly Net Income VS EBIT VS OCF VS FCFAWRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

AWRE has a Return On Assets of -12.65%. This is in the lower half of the industry: AWRE underperforms 63.38% of its industry peers.
AWRE's Return On Equity of -17.12% is in line compared to the rest of the industry. AWRE outperforms 44.72% of its industry peers.
Industry RankSector Rank
ROA -12.65%
ROE -17.12%
ROIC N/A
ROA(3y)-9.86%
ROA(5y)-11.27%
ROE(3y)-13.32%
ROE(5y)-14.13%
ROIC(3y)N/A
ROIC(5y)N/A
AWRE Yearly ROA, ROE, ROICAWRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

With an excellent Gross Margin value of 93.36%, AWRE belongs to the best of the industry, outperforming 99.30% of the companies in the same industry.
In the last couple of years the Gross Margin of AWRE has remained more or less at the same level.
AWRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y0.84%
AWRE Yearly Profit, Operating, Gross MarginsAWRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

AWRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AWRE has been increased compared to 1 year ago.
Compared to 5 years ago, AWRE has less shares outstanding
AWRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AWRE Yearly Shares OutstandingAWRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AWRE Yearly Total Debt VS Total AssetsAWRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.38, we must say that AWRE is in the distress zone and has some risk of bankruptcy.
AWRE has a Altman-Z score of 0.38. This is in the lower half of the industry: AWRE underperforms 66.90% of its industry peers.
There is no outstanding debt for AWRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC9.02%
AWRE Yearly LT Debt VS Equity VS FCFAWRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 4.64 indicates that AWRE has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.64, AWRE belongs to the best of the industry, outperforming 85.92% of the companies in the same industry.
AWRE has a Quick Ratio of 4.64. This indicates that AWRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.64, AWRE belongs to the top of the industry, outperforming 85.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.64
Quick Ratio 4.64
AWRE Yearly Current Assets VS Current LiabilitesAWRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

AWRE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.70%.
AWRE shows a decrease in Revenue. In the last year, the revenue decreased by -9.69%.
The Revenue has been growing slightly by 7.35% on average over the past years.
EPS 1Y (TTM)-8.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-9.69%
Revenue growth 3Y1.06%
Revenue growth 5Y7.35%
Sales Q2Q%-18.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AWRE Yearly Revenue VS EstimatesAWRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AWRE Yearly EPS VS EstimatesAWRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AWRE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AWRE Price Earnings VS Forward Price EarningsAWRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWRE Per share dataAWRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AWRE!.
Industry RankSector Rank
Dividend Yield N/A

AWARE INC/MASS

NASDAQ:AWRE (6/20/2025, 8:16:41 PM)

1.87

-0.05 (-2.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)08-06 2025-08-06
Inst Owners20.91%
Inst Owner Change0.7%
Ins Owners42.19%
Ins Owner Change5.17%
Market Cap39.44M
Analysts82.86
Price TargetN/A
Short Float %0.47%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.38
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.79
BVpS1.4
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.65%
ROE -17.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.36%
FCFM N/A
ROA(3y)-9.86%
ROA(5y)-11.27%
ROE(3y)-13.32%
ROE(5y)-14.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y0.84%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.87%
Cap/Sales 0.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.64
Quick Ratio 4.64
Altman-Z 0.38
F-Score6
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)35.61%
Cap/Depr(5y)39.38%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.69%
Revenue growth 3Y1.06%
Revenue growth 5Y7.35%
Sales Q2Q%-18.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.08%
OCF growth 3YN/A
OCF growth 5YN/A